Looking to commercialize its virtual reality mental health treatment, Oxford VR has announced that it raked in $4.11 (£3.2 million) in funding. Investors included Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital, and GT Healthcare Capital Partners.
"Our focus is on developing clinically validated, cost-effective, user-centred treatments for clinical conditions with...
An investigation published yesterday in The Lancet Psychiatry found that automated cognitive intervention delivered via sessions with a consumer-grade virtual reality headset effectively reduced individuals’ fear of heights, and was generally well received by those participating in the study.
The results, researchers wrote, suggest that similar automated VR treatments could potentially be viable...
